Your browser doesn't support javascript.
loading
The current state of the platelet supply in the US and proposed options to decrease the risk of critical shortages.
Stubbs, James R; Homer, Mary J; Silverman, Toby; Cap, Andrew P.
Afiliação
  • Stubbs JR; Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Homer MJ; Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA.
  • Silverman T; Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA.
  • Cap AP; Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, US Army Institute of Surgical Research and Uniformed Services University, JBSA-FT Sam Houston, Texas, USA.
Transfusion ; 61(1): 303-312, 2021 01.
Article em En | MEDLINE | ID: mdl-33098328
ABSTRACT
Due to circumstances such as increased demand and an aging donor pool, the likelihood of critical platelet shortages is increasing. The platelet supply could be improved through the expansion of the donor pool, the identification and sustained utilization of high-quality donors, and changes in component processing and storage that result in a longer platelet shelf-life. Refrigerated platelets, stored at 1° to 6°C, have the potential to improve patient safety by decreasing the risk of bacterial contamination while concurrently allowing for a longer storage period (eg, 14 days) and improved hemostatic effectiveness in actively bleeding patients. An approach utilizing remuneration of apheresis platelet donors combined with pathogen reduction of the platelet components could be used as a means to increase the donor pool and identify and sustain safe, reliable, high-quality donors. Remuneration might provide an incentive for underutilized populations (eg, individuals <30 years old) to enter the apheresis platelet donor population resulting in a significant expansion of the platelet donor pool. Over time, approaches such as the use of refrigerated platelets, platelet donor remuneration, and the application of pathogen reduction technology, might serve to attract a large, reliable, and safe donor base that provides platelet collections with high yields, longer shelf-lives and, excellent hemostatic function.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Plaquetas / Transfusão de Plaquetas / Segurança do Sangue Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Plaquetas / Transfusão de Plaquetas / Segurança do Sangue Idioma: En Ano de publicação: 2021 Tipo de documento: Article